Biogen (BIIB) Current Taxes (2009 - 2026)

Biogen's Current Taxes history runs 18 years deep, the most recent figure standing at $93.6 million for Q1 2026.

• In Q1 2026, Current Taxes fell 85.05% year-over-year to $93.6 million; the TTM figure through Mar 2026 stood at $93.6 million (down 85.05% YoY), while the FY2025 annual figure was $114.8 million, down 79.06% from the prior year.
• Current Taxes was $93.6 million for Q1 2026 at Biogen, down from $114.8 million in the prior quarter.
• In the past five years, Current Taxes ranged from a high of $626.1 million in Q1 2025 to a low of $93.6 million in Q1 2026.
• Historically, Current Taxes has averaged $277.0 million across 5 years, with a median of $257.4 million in 2023.
• The sharpest annual moves came in 2025 and 2026: Current Taxes soared 170.8% in 2025, then tumbled 85.05% in 2026.
• A 5-year view of Current Taxes shows it stood at $259.9 million in 2022, then dropped by 0.96% to $257.4 million in 2023, then jumped by 113.01% to $548.3 million in 2024, then slumped by 79.06% to $114.8 million in 2025, then declined by 18.47% to $93.6 million in 2026.
• The last three Current Taxes figures came in at $93.6 million (Q1 2026), $114.8 million (Q4 2025), and $103.3 million (Q3 2025), per Business Quant data.